Natural products that target p53 for cancer therapy

被引：0
作者：
Tsukamoto, Sachiko [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Nat Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
来源：
JOURNAL OF NATURAL MEDICINES | 2025年 / 79卷 / 04期
基金：
日本学术振兴会;
关键词：
Natural products; p53; reactivation; Tumor suppressor; Cancer therapy; SULFONATED SERINOL DERIVATIVES; UBIQUITIN-ACTIVATING ENZYME; POTENT CYTOTOXIC MACROLIDE; MARINE-DERIVED FUNGUS; MUTANT P53; MULTIDRUG-RESISTANCE; PROTEASOME INHIBITOR; MDM2; INHIBITOR; STEROL ACETATE; SWINHOLIDE-A;
D O I：
10.1007/s11418-025-01906-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Wild-type p53 acts as a tumor suppressor, but p53 is frequently mutated and inactivated in tumor cells, promoting cancer progression, invasion, and metastasis. Thus, compounds that reactivate p53 may be leveraged for cancer treatment, and the development of drugs targeting p53 reactivation is actively progressing. Notably, natural products exhibit diverse structures and biological activities and are used as therapeutic agents for various diseases worldwide. This review discusses the natural products that inhibit p53 degradation through p53-Mdm2 interaction, promote p53 reactivation by inducing conformational changes, and exhibit p53-dependent growth inhibition.
引用
收藏
页码：725 / 737
页数：13
相关论文
共 79 条
[51]   Mechanisms underlying ubiquitination [J].
Pickart, CM .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :503-533
[52]   Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes [J].
Reyes-Turcu, Francisca E. ;
Ventii, Karen H. ;
Wilkinson, Keith D. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :363-397
[53]   p53 -: A natural cancer killer:: Structural insights and therapeutic concepts [J].
Roemer, Lin ;
Klein, Christian ;
Dehner, Alexander ;
Kessler, Horst ;
Buchner, Johannes .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (39) :6440-6460
[54]   Pestones A and B from a Fungus Pestalotiopsis sp. Bound to Mutant p53 and Changed Its Conformation [J].
Sadahiro, Yusaku ;
Okubo, Misaki ;
Hitora, Yuki ;
Hitora-Imamura, Natsuko ;
Kotani, Shunsuke ;
Tsukamoto, Sachiko .
JOURNAL OF NATURAL PRODUCTS, 2025, 88 (02) :546-553
[55]   Colletofragarone A2 Inhibits Cancer Cell Growth In Vivo and Leads to the Degradation and Aggregation of Mutant p53 [J].
Sadahiro, Yusaku ;
Hitora, Yuki ;
Kimura, Ichiro ;
Hitora-Imamura, Natsuko ;
Onodera, Risako ;
Motoyama, Keiichi ;
Tsukamoto, Sachiko .
CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (09) :1598-1603
[56]   Colletofragarone A2 and Colletoins A-C from a Fungus Colletotrichum sp. Decrease Mutant p53 Levels in Cells [J].
Sadahiro, Yusaku ;
Hitora, Yuki ;
Tsukamoto, Sachiko .
JOURNAL OF NATURAL PRODUCTS, 2021, 84 (12) :3131-3137
[57]   COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo [J].
Salim, Kowthar Y. ;
Vareki, Saman Maleki ;
Danter, Wayne R. ;
Koropatnick, James .
ONCOTARGET, 2016, 7 (27) :41363-41379
[58]   Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies [J].
Shen, Jinze ;
Wang, Qurui ;
Mao, Yunan ;
Gao, Wei ;
Duan, Shiwei .
MEDCOMM, 2023, 4 (03)
[59]   Petroquinones: trimeric and dimeric xestoquinone derivatives isolated from the marine sponge Petrosia alfiani [J].
Tanokashira, Natsuki ;
Kukita, Sanako ;
Kato, Hikaru ;
Nehira, Tatsuo ;
Angkouw, Esther D. ;
Mangindaan, Remy E. P. ;
de Voogd, Nicole J. ;
Tsukamoto, Sachiko .
TETRAHEDRON, 2016, 72 (35) :5530-5540
[60]   Carfilzomib: A Second-Generation Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma [J].
Thompson, Jennifer L. .
ANNALS OF PHARMACOTHERAPY, 2013, 47 (01) :56-62
12345678